CTLA4 Antikörper (AA 36-135)
Kurzübersicht für CTLA4 Antikörper (AA 36-135) (ABIN514751)
Target
Alle CTLA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 36-135
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant CTLA4.
-
Sequenz
- KAMHVAQPAV VLASSRGIAS FVCEYASPGK ATEVRVTVLR QADSQVTEVC AATYMMGNEL TFLDDSICTG TSSGNQVNLT IQGLRAMDTG LYICKVELMY
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- CTLA4 (NP_005205, 36 a.a. ~ 135 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis." in: EJNMMI research, Vol. 6, Issue 1, pp. 1, (2016) (PubMed).
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Andere Bezeichnung
- CTLA4
-
Hintergrund
-
Full Gene Name: cytotoxic T-lymphocyte-associated protein 4
Synonyms: CD152,CELIAC3,CTLA-4,GSE,IDDM12 -
Gen-ID
- 1493
-
NCBI Accession
- NM_005214
-
Pathways
- Cancer Immune Checkpoints
Target
-